Yoshio Koyanagi

Basic Research into Four Years and Comprehensive Evaluation

Hiroshi Aida, Toshihide Yasui, Takumi Nakanishi, 2007 .

A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif

Yusuke Nakano, Yoshio Koyanagi, Kei Sato, 2017, Retrovirology.

HIV-1 Vpr Accelerates Viral Replication during Acute Infection by Exploitation of Proliferating CD4+ T Cells In Vivo

Kazuyuki Aihara, Shingo Iwami, Yukihito Ishizaka, 2013, PLoS pathogens.

Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

Yoshio Koyanagi, Y. Koyanagi, Hirotaka Ebina, 2013, Scientific Reports.

N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation

Osamu Takeuchi, Daron M Standley, Sho Miyamoto, 2019, Nature Microbiology.

Cell-to-cell infection by HIV contributes over half of virus infection

Kazuyuki Aihara, Shinji Nakaoka, Shingo Iwami, 2015, eLife.

Solution RNA structures of the HIV-1 dimerization initiation site in the kissing-loop and extended-duplex dimers.

Gota Kawai, Hiroshi Takaku, Yoshio Koyanagi, 2005, Journal of biochemistry.

APOBEC3D and APOBEC3F Potently Promote HIV-1 Diversification and Evolution in Humanized Mouse Model

Kazuyuki Aihara, Shingo Iwami, Junko S. Takeuchi, 2014, PLoS pathogens.

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

Naoki Yamamoto, Yuetsu Tanaka, Hiroshi Takaku, 2003, Proceedings of the National Academy of Sciences of the United States of America.